首页|丝裂霉素C联合尿道内切开术治疗尿道狭窄的研究进展

丝裂霉素C联合尿道内切开术治疗尿道狭窄的研究进展

扫码查看
直视下尿道内切开术是目前治疗尿道狭窄的主要方式之一。由于术后瘢痕形成,狭窄复发率较高,多数患者需重复多次手术。丝裂霉素C可以通过抑制成纤维细胞的增殖,减少肉芽组织和瘢痕形成。有研究发现,丝裂霉素C联合尿道内切开术可以明显降低尿道狭窄的复发率。本文通过系统性文献回顾,对丝裂霉素C联合尿道内切开术的用药方式、安全性、有效性和局限性进行总结,以期为临床应用提供参考。
Research progress of mitomycin C combined with internal urethrotomy in the treatment of urethral stricture
Direct vision urethral incision is currently one of the main methods for treating urethral stricture.Due to post-operative scar formation,the recurrence rate of stricture is high,and most patients need to repeat multiple surgeries.Mitomy-cin C can reduce granulation tissue and scar formation by inhibiting fibroblast proliferation.Studies have found mitomycin com-bined with internal urethrotomy for urethral stricture can greatly reduce the recurrence rate of treating urethral stricture.This ar-ticle summarizes the medication,safety,efficacy,and limitations of internal urethrotomy combined with mitomycin C through a systematic literature review,to provide reference for clinical practice.

mitomycin Cinternal urethrotomyurethral stricture

王程、秦琪琪

展开 >

杭州市余杭区第二人民医院 泌尿外科,杭州 311121

丝裂霉素C 尿道内切开术 尿道狭窄

2024

临床药物治疗杂志
北京药学会

临床药物治疗杂志

CSTPCD
影响因子:1.07
ISSN:1672-3384
年,卷(期):2024.22(2)
  • 22